DK1193266T3 - Quinolincarboxylsyrederivat eller salte deraf - Google Patents

Quinolincarboxylsyrederivat eller salte deraf

Info

Publication number
DK1193266T3
DK1193266T3 DK00940804T DK00940804T DK1193266T3 DK 1193266 T3 DK1193266 T3 DK 1193266T3 DK 00940804 T DK00940804 T DK 00940804T DK 00940804 T DK00940804 T DK 00940804T DK 1193266 T3 DK1193266 T3 DK 1193266T3
Authority
DK
Denmark
Prior art keywords
carboxylic acid
salts
acid derivatives
quinoline carboxylic
extremely high
Prior art date
Application number
DK00940804T
Other languages
Danish (da)
English (en)
Inventor
Akira Yazaki
Yoshiko Niino
Yasuhiro Kuramoto
Yuzo Hirao
Norihiro Hayashi
Hirotaka Amano
Yoshihiro Ohshita
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Application granted granted Critical
Publication of DK1193266T3 publication Critical patent/DK1193266T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00940804T 1999-07-01 2000-06-22 Quinolincarboxylsyrederivat eller salte deraf DK1193266T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01
PCT/JP2000/004096 WO2001002390A1 (fr) 1999-07-01 2000-06-22 Derive d'acide quinolinecarboxylique et ses sels

Publications (1)

Publication Number Publication Date
DK1193266T3 true DK1193266T3 (da) 2003-11-24

Family

ID=16207019

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00940804T DK1193266T3 (da) 1999-07-01 2000-06-22 Quinolincarboxylsyrederivat eller salte deraf

Country Status (25)

Country Link
US (1) US6858625B1 (no)
EP (1) EP1193266B1 (no)
JP (1) JP3477465B2 (no)
KR (1) KR100628414B1 (no)
CN (1) CN1157389C (no)
AT (1) ATE248162T1 (no)
AU (1) AU766014B2 (no)
BR (1) BR0012192A (no)
CA (1) CA2376760C (no)
CZ (1) CZ302033B6 (no)
DE (1) DE60004846T2 (no)
DK (1) DK1193266T3 (no)
ES (1) ES2206257T3 (no)
HK (1) HK1047103B (no)
HU (1) HUP0201549A3 (no)
IL (2) IL147043A0 (no)
MX (1) MXPA02000103A (no)
NO (1) NO321803B1 (no)
NZ (1) NZ516201A (no)
PT (1) PT1193266E (no)
RU (1) RU2236408C2 (no)
SK (1) SK285814B6 (no)
TW (1) TW576832B (no)
WO (1) WO2001002390A1 (no)
ZA (1) ZA200110357B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3477466B2 (ja) 1999-09-02 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
WO2006054623A1 (ja) 2004-11-17 2006-05-26 Wakunaga Pharmaceutical Co., Ltd. 新規ピリドンカルボン酸誘導体又はその塩
KR20110091504A (ko) * 2008-09-24 2011-08-11 립-엑스 파마슈티칼즈, 인크. 퀴놀론 화합물의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177302C (no) 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
CA2168764C (en) 1993-08-13 2000-01-18 Sung June Yoon Novel quinolone carboxylic acid derivatives
CN1105715C (zh) * 1995-09-22 2003-04-16 涌永制药株式会社 新型吡啶酮羧酸衍生物或其盐以及以它们为有效成分的抗菌剂
PT897919E (pt) 1996-04-19 2004-11-30 Wakunaga Pharma Co Ltd Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
KR100516379B1 (ko) 1996-11-28 2005-09-26 와쿠나가 세이야쿠 가부시키 가이샤 신규 피리돈카르복실산 유도체 또는 그의 염 및 이를 유효 성분으로 하는 의약
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
IL147043A0 (en) 2002-08-14
SK285814B6 (sk) 2007-08-02
BR0012192A (pt) 2002-06-18
SK19162001A3 (sk) 2002-06-04
NO321803B1 (no) 2006-07-03
IL147043A (en) 2007-07-04
ZA200110357B (en) 2002-12-18
EP1193266A4 (en) 2002-08-14
EP1193266A1 (en) 2002-04-03
TW576832B (en) 2004-02-21
MXPA02000103A (es) 2003-07-21
RU2236408C2 (ru) 2004-09-20
CN1157389C (zh) 2004-07-14
CA2376760C (en) 2008-11-25
US6858625B1 (en) 2005-02-22
DE60004846T2 (de) 2004-06-03
NO20016378D0 (no) 2001-12-27
WO2001002390A1 (fr) 2001-01-11
CN1358183A (zh) 2002-07-10
ATE248162T1 (de) 2003-09-15
CA2376760A1 (en) 2001-01-11
JP3477465B2 (ja) 2003-12-10
KR100628414B1 (ko) 2006-09-26
HUP0201549A2 (en) 2002-08-28
PT1193266E (pt) 2003-12-31
KR20020020733A (ko) 2002-03-15
NO20016378L (no) 2002-02-28
EP1193266B1 (en) 2003-08-27
ES2206257T3 (es) 2004-05-16
AU5567900A (en) 2001-01-22
CZ20014598A3 (cs) 2002-05-15
CZ302033B6 (cs) 2010-09-08
DE60004846D1 (de) 2003-10-02
NZ516201A (en) 2003-06-30
AU766014B2 (en) 2003-10-09
HK1047103B (zh) 2005-04-08
HK1047103A1 (en) 2003-02-07
HUP0201549A3 (en) 2003-11-28

Similar Documents

Publication Publication Date Title
AR048859A1 (es) Utilizacion de derivados de indazol carboxamidas para la preparacion de un medicamento destinado al tratamiento y a la prevencion del paludismo
HUP0400781A2 (hu) Eljárás (R)- vagy (S)-lansoprazol kristályosítására, az előállított kristályok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE309194T1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
HUT70482A (en) Immunopotentiatory pharmaceutical compositions containing carbonylgroups
DK0657448T3 (da) •nbeholderfremgangsmåde til fremstilling af quinoloncarboxylsyrederivater
KR870006034A (ko) 항균제로서의 5-아미노 및 5-하이드록시- 6,8-디플루오로퀴놀론
NO884958L (no) Kinolinkarboksylsyrederivater.
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
IL101009A0 (en) 2-substituted quinolines,preparation and pharmaceutical compositions containing them
DK1193266T3 (da) Quinolincarboxylsyrederivat eller salte deraf
CY1112057T1 (el) Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι
HUP0401562A2 (hu) Kinolinszármazékok és alkalmazásuk tumorellenes szerekként és ezeket tartalmazó gyógyászati készítmények
ATE373502T1 (de) Carbostyril-derivative zur beschleunigten speichelabsonderung
UA91549C2 (ru) Производные хинолина как антибактериальные агенты
JP3424038B2 (ja) 合成抗菌剤水性組成物
JPS63188626A (ja) ピリドンカルボン酸の可溶化方法
CY1110244T1 (el) Χαμηλης υγροσκοπικοτητας αριπιπραζολη ως φαρμακευτικη ουσια και μεθοδοι για την παρασκευη της
RU2002102491A (ru) Производные хинолинкарбоновой кислоты или их соли
RU2007122499A (ru) Новые производные пиридонкарбоновой кислоты или их соли
EP1219618A4 (en) QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
ATE403644T1 (de) Amidinophenylbrenztraubensäure-derivat
KR920006345A (ko) 신규한 퀴놀론 카르복실산 유도체
MXPA04000952A (es) Sales de derivados de acido 1,2,3-4-tetrahidro-isoquinolin-2-carboxilico.
JPH0459726A (ja) ピリドンカルボン酸の可溶化方法
KR950000690A (ko) 신규 피리돈 카르복실산 유도체 및 그 제조방법